15-lipoxygenase and cyclooxygenase expression profile and their related modulators in COVID-19 infection
- PMID: 37716021
- DOI: 10.1016/j.plefa.2023.102587
15-lipoxygenase and cyclooxygenase expression profile and their related modulators in COVID-19 infection
Abstract
Background: The role of the lipoxygenase (LOX) and cyclooxygenase (COX) enzymes in maintaining cellular homeostasis and regulating immune responses promoted us in this study to analyze the pattern of changes in 15-lipoxygenase and cyclooxygenase isoforms and their related cytokines in SARS-CoV-2 infection.
Methods: 15-LOX-1, 15-LOX-2, COX-1 and COX-2 gene expression levels were determined using qRT-PCR in nasopharynx specimens from patients with severe [N = 40] and non-severe [N = 40] confirmed SARS-CoV-2 infections and healthy controls. Circulating levels of lL-6, lL-10, PGE2, and IFN-γ were measured in patients and healthy controls using ELISA assay. The associations between the measured variables and the patient's clinic-pathological characteristics were assessed for all groups.
Results: The expression level of 15-LOX-1 was elevated significantly in male patients with severe infection; although female patients showed a different expression profile. 15-LOX-2 expression level was considerably increased in male patients with severe infection; while changes in its expression remained inconclusive in female patients. The relationship between 15-LOX expression and the male gender was prominent. Both COX isoforms expression showed elevation in male and female patients that were correlated with disease severity. The simultaneous increase in lL-6, PGE2 and IFN-γ levels also decrease in lL-10 in patients with severe infection indicating the possible regulatory network related to the COX and 15-LOX enzymes in the output of the SARS-CoV-2 infection.
Conclusion: The results of this study determined the pattern of possible changes in key enzymes of prostaglandin and eicosanoids synthesis pathway and their mediators, which can be helpful in mapping the SARS-CoV-2 pathogenicity and pharmaceutical approaches.
Keywords: 15-lipoxygenase; Cyclooxygenase; Interferon gamma; Interleukin-10; Interleukin-6; Prostaglandin-E2; SARS-CoV-2.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that there is no conflict of interest.
Similar articles
-
Reduced lipoxygenase and cyclooxygenase mediated signaling in PBMC of atopic dermatitis patients.Prostaglandins Other Lipid Mediat. 2013 Dec;107:35-42. doi: 10.1016/j.prostaglandins.2013.03.003. Epub 2013 Apr 18. Prostaglandins Other Lipid Mediat. 2013. PMID: 23603610
-
Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells.World J Surg Oncol. 2012 Sep 26;10:200. doi: 10.1186/1477-7819-10-200. World J Surg Oncol. 2012. PMID: 23013454 Free PMC article.
-
Celastrol modulates inflammation through inhibition of the catalytic activity of mediators of arachidonic acid pathway: Secretory phospholipase A2 group IIA, 5-lipoxygenase and cyclooxygenase-2.Pharmacol Res. 2016 Nov;113(Pt A):265-275. doi: 10.1016/j.phrs.2016.08.035. Epub 2016 Sep 3. Pharmacol Res. 2016. PMID: 27597642
-
Involvement of eicosanoids in the pathogenesis of pancreatic cancer: the roles of cyclooxygenase-2 and 5-lipoxygenase.World J Gastroenterol. 2014 Aug 21;20(31):10729-39. doi: 10.3748/wjg.v20.i31.10729. World J Gastroenterol. 2014. PMID: 25152576 Free PMC article. Review.
-
Non-prostaglandin eicosanoids in fever and anapyrexia.Front Biosci. 2004 Sep 1;9:3339-55. doi: 10.2741/1486. Front Biosci. 2004. PMID: 15353362 Review.
Cited by
-
Beyond prediction: unveiling the prognostic power of μ-opioid and cannabinoid receptors, alongside immune mediators, in assessing the severity of SARS-CoV-2 infection.BMC Infect Dis. 2024 Apr 12;24(1):398. doi: 10.1186/s12879-024-09280-6. BMC Infect Dis. 2024. PMID: 38609845 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous